Related Experiment Video
Updated: Mar 6, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Do systematic reviews on pediatric topics need special methodological considerations?
Mufiza Farid-Kapadia1, Lisa Askie2, Lisa Hartling3
1Child Health Evaluative Sciences, Research Institute, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
Insights
Pediatric systematic reviews face unique challenges. This study identifies these issues and proposes a new checklist to improve the quality and reporting of child health systematic reviews.
Area of Science:
- Child Health Research
- Evidence Synthesis
- Systematic Review Methodology
Background:
- Systematic reviews are crucial for healthcare decisions but face challenges in pediatric research.
- Existing guidelines like PRISMA do not fully address pediatric-specific methodological issues.
- Uncertainty in pediatric systematic reviews hinders effective decision-making in child health.
Purpose of the Study:
- To identify methodological challenges unique to pediatric systematic reviews.
- To propose a process for addressing these challenges in the design, conduct, and reporting of pediatric systematic reviews.
- To develop a consensus-based checklist for planning and reporting pediatric systematic reviews.
Main Methods:
- Identification of pediatric-specific methodological challenges in systematic reviews.
- Proposal of a process to address these challenges.
- Development of a consensus-based checklist (PRISMA-PC and PRISMA-C) for pediatric systematic reviews.
Main Results:
- Key challenges include defining pediatric populations, selecting appropriate comparators, and using validated outcomes.
- Lack of pediatric-sensitive search strategies and inconsistent age subgroup definitions in meta-analyses were identified.
- The study proposes new reporting standards tailored for pediatric systematic reviews.
Conclusions:
- Standardized approaches are needed to overcome methodological hurdles in pediatric systematic reviews.
- The proposed checklist will enhance the transparency and quality of pediatric systematic reviews.
- Improved systematic reviews will facilitate knowledge translation, enhancing child health outcomes and care delivery.
Background:
Systematic reviews are key tools to enable decision making by healthcare providers and policymakers. Despite the availability of the evidence based Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA-2009 and PRISMA-P 2015) statements that were developed to improve the transparency and quality of reporting of systematic reviews, uncertainty on how to deal with pediatric-specific methodological challenges of systematic reviews impairs decision-making in child health. In this paper, we identify methodological challenges specific to the design, conduct and reporting of pediatric systematic reviews, and propose a process to address these challenges.
Discussion:
One fundamental decision at the outset of a systematic review is whether to focus on a pediatric population only, or to include both adult and pediatric populations. Both from the policy and patient care point of view, the appropriateness of interventions and comparators administered to pre-defined pediatric age subgroup is critical. Decisions need to be based on the biological plausibility of differences in treatment effects across the developmental trajectory in children. Synthesis of evidence from different trials is often impaired by the use of outcomes and measurement instruments that differ between trials and are neither relevant nor validated in the pediatric population. Other issues specific to pediatric systematic reviews include lack of pediatric-sensitive search strategies and inconsistent choices of pediatric age subgroups in meta-analyses. In addition to these methodological issues generic to all pediatric systematic reviews, special considerations are required for reviews of health care interventions' safety and efficacy in neonatology, global health, comparative effectiveness interventions and individual participant data meta-analyses. To date, there is no standard approach available to overcome this problem. We propose to develop a consensus-based checklist of essential items which researchers should consider when they are planning (PRISMA-PC-Protocol for Children) or reporting (PRISMA-C-reporting for Children) a pediatric systematic review. Available guidelines including PRISMA do not cover the complexity associated with the conduct and reporting of systematic reviews in the pediatric population; they require additional and modified standards for reporting items. Such guidance will facilitate the translation of knowledge from the literature to bedside care and policy, thereby enhancing delivery of care and improving child health outcomes.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

